Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Companion Animal Vaccines Market – Insights

There are two types of small companion animal vaccine available: ‘infectious’ or ‘non-infectious’ in nature. Infectious vaccines used in dogs and cats contain organisms that are attenuated to reduce virulence. Non-infectious vaccines contain an inactivated but antigenically intact virus or organism.

The global companion animal vaccines market is estimated to account for US$ 4,682.2 Mn in terms of value by the end of 2027.

Global Companion Animal Vaccines Market: Drivers

Increasing adoption of companion animals is expected to boost growth of the global companion animal vaccines market over the forecast period. For instance, according to America Veterinary Medical Association, the number of dogs in the U.S. was 76,811,305 in 2018, compared to 69,926,000 in 2012.

Moreover, increasing expenditure on animal healthcare is also expected to aid in growth of the market. For instance, according to The American Pet Products Association’s estimates in March 2018, the overall spending in the U.S. pet industry is expected to witness a 3.7% increase in 2018 compared to 2017.

Europe region held dominant position in the global companion animal vaccines market in 2019, accounting for 30.7% share in terms of value, followed by 2027.

Figure 1. Global Companion Animal Vaccines Market Share (%), by Region, 2019

Companion Animal Vaccines  | Coherent Market Insights

Global Companion Animal Vaccines Market: Restraints

Gaps in epidemiological knowledge of certain virulent veterinary diseases is expected to hinder growth of the global companion animal vaccines market growth.  There exists large gap in understanding the epidemiology pattern of veterinary diseases due to variations in disease patterns for endemic countries. For instance, Newcastle Disease for poultry and other birds. Virulent Newcastle disease virus (vNDV) is evolving simultaneously at different locations due to isolates that are distributed worldwide and mutate rapidly. This leads to large knowledge gaps on development of multiple vNDV genotypes, thereby restricting R&D of effective vaccines against Newcastle Disease.

Moreover, challenges in identifying and understanding antigen/immunogenic structures are also expected to hamper growth of the market. Such scenario leads to deficiency in fitting proper epidemiological models, thereby creating shortfall in logical representation of the epidemiology of disease transmission and its associated processes. As per marketplace discussions, veterinary research institutes need to maintain closer collaborations with vaccine manufacturers to gain deeper insights into antigen/immunogenic structures, the method through which the vaccine works and closer correlates of symptoms that could be treated with these vaccines. In this regard, manufacturers and research organizations need to create better understanding of the host immune response, protective immunity, and immunogenetics.

Global Companion Animal Vaccines Market: Opportunities

Players in the market can focused on R&D and launch of vaccines for H5N1 (Guangdong Lineage) in cats and dogs. There is no USDA-licensed vaccine for highly pathogenic avian influenza (HPAI) affecting pets (feline, canine, birds) in the U.S. The incubation time is very small, which increases the demand for immediate vaccines.

Moreover, growing awareness towards sterilization process of companion animals is also expected to offer lucrative growth opportunities for players in the market. Companion animal sterilization is an important process to control overpopulation. This in turn provides opportunity for companion animal vaccine manufacturers develop safe and effective sterilization vaccines.

Companion Animal Vaccines  | Coherent Market Insights

Attenuated Live Vaccines segment in the global companion animal vaccines market was valued at US$ 930.6 Mn in 2019 and is expected to reach US$ 1,655.9 Mn by 2027 at a CAGR of 7.5% during the forecast period.

Market Trends/Key Takeaways

Major regulatory bodies are focused on updating guidelines related to feline retrovirus. For instance, in January 2020, The American Association of Feline Practitioners (AAFP) released updated Feline Retrovirus Testing and Management Guidelines to the veterinary community, which will be published in the Journal of Feline Medicine and Surgery.

Government and private organizations are focused on offering vaccines at lower cost. For instance, Killeen Animal Services, Texas, U.S., announced to host a low cost pet vaccination clinic in February 2020.

Regulations

U.S.

  • The U.S. Department of Agriculture (USDA) and the Center for Veterinary Biologics (CVB) within the USDA’s Animal and Plant Health Inspection Service (APHIS) is the main group formulates regulations for veterinary biologics
  • The amended version (1985) of the Virus-Serum-Toxin Act of 1913 and Title 9 of the Code of Federal Regulations (mainly sections 101–118) control the production and movement of veterinary biologics in the U.S.
  • Major investigational guidelines are applied to ensure that the biologics are free of disease-producing agents and products exhibit proper safety, potency and efficacy
  • The U.S. CVB also focuses on developing standards and procedures for product release, issuing licenses and permits, monitoring and inspecting products and facilities, and controlling field tests and release of veterinary biological drugs among others.

Value Chain Analysis

Companion Animal Vaccines  | Coherent Market Insights

Global Companion Animal Vaccines Market: Competitive Landscape

Major players operating in the global companion animal vaccines market include, Bayer Healthcare, Vétoquinol S.A, Boehringer Ingelheim, Ceva Sante Animal S.A., Eli Lilly and Company (Elcano), Heska Co., Merck Animal Health, Merial (Boehringer Ingelheim),Virbac, and Zoetis.

Global Companion Animal Vaccines Market: Key Developments

Key players in the market are focused on adopting M&A strategies to expand their produxt portfolio. For instance, in January 2020, Heska Corporation, a provider of advanced veterinary diagnostic and specialty products, acquired CVM Diagnostico Veterinario, S.L. and CVM Ecografía, S.L., providers of imaging and blood testing products to the companion animals.

Major players in the market are also focused on adopting various marketing strategies to enhance their market share. For instance, in February 2019, Boehringer Ingelheim announced to exhibit at the 2019 International Producing and Processing Expo (IPPE), with its vector vaccines Vaxxitek HVT + IBD and Newxxitek HVT + ND.

Companion animal vaccines are used to protect and treat companion animals such as cats, and dogs from diseases such as infectious canine hepatitis, parvovirus, rabies, and etc. Increasing expenditure on animal healthcare, increasing pet ownership, increasing incidence and prevalence of zoonotic disease, are major driver attributing to the growth of global companion animal vaccines market during the forecasted period.

Key features of the study:

  • This report provides in-depth analysis of the global Companion Animal Vaccines and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global Companion Animal Vaccines based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Bayer Healthcare, Vétoquinol S.A, Boehringer Ingelheim, Ceva Sante Animal S.A., Eli Lilly and Company (Elcano), Heska Co., Merck Animal Health, Merial (Boehringer Ingelheim),Virbac, and Zoetis.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Companion Animal Vaccines report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  •  Companion Animal Vaccines Market, By Product Type:
    • Attenuated Live Vaccines
    • Conjugate Vaccines
    • Inactivated Vaccines
    • Subunit Vaccines
    • Toxoid Vaccines
    • DNA Vaccines
    • Recombinant Vaccines
  • Companion Animal Vaccines Market, By Species Type:
    • Canine
    • Avian
    • Feline
  • Companion Animal Vaccines Market, By Distribution Channel:
    • Veterinary Clinics
    • Veterinary Hospitals
    • Veterinary Research Institutes
    • Retail Pharmacies & Others
  • Companion Animal Vaccines Market, By Region:
    • North America
      • By Product Type:
        • Attenuated Live Vaccines
        • Conjugate Vaccines
        • Inactivated Vaccines
        • Subunit Vaccines
        • Toxoid Vaccines
        • DNA Vaccines
        • Recombinant Vaccines
      • By Species
        • Canine
        • Avian
        • Feline
      • By Distribution Channel
        • Veterinary Clinics
        • Veterinary Hospitals
        • Veterinary Research Institutes
        • Retail Pharmacies & Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Attenuated Live Vaccines
        • Conjugate Vaccines
        • Inactivated Vaccines
        • Subunit Vaccines
        • Toxoid Vaccines
        • DNA Vaccines
        • Recombinant Vaccines
      • By Species
        • Canine
        • Avian
        • Feline
      • By Distribution Channel
        • Veterinary Clinics
        • Veterinary Hospitals
        • Veterinary Research Institutes
        • Retail Pharmacies & Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Attenuated Live Vaccines
        • Conjugate Vaccines
        • Inactivated Vaccines
        • Subunit Vaccines
        • Toxoid Vaccines
        • DNA Vaccines
        • Recombinant Vaccines
      • By Species
        • Canine
        • Avian
        • Feline
      • By Distribution Channel
        • Veterinary Clinics
        • Veterinary Hospitals
        • Veterinary Research Institutes
        • Retail Pharmacies & Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Attenuated Live Vaccines
        • Conjugate Vaccines
        • Inactivated Vaccines
        • Subunit Vaccines
        • Toxoid Vaccines
        • DNA Vaccines
        • Recombinant Vaccines
      • By Species
        • Canine
        • Avian
        • Feline
      • By Distribution Channel
        • Veterinary Clinics
        • Veterinary Hospitals
        • Veterinary Research Institutes
        • Retail Pharmacies & Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Attenuated Live Vaccines
        • Conjugate Vaccines
        • Inactivated Vaccines
        • Subunit Vaccines
        • Toxoid Vaccines
        • DNA Vaccines
        • Recombinant Vaccines
      • By Species
        • Canine
        • Avian
        • Feline
      • By Distribution Channel
        • Veterinary Clinics
        • Veterinary Hospitals
        • Veterinary Research Institutes
        • Retail Pharmacies & Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Attenuated Live Vaccines
        • Conjugate Vaccines
        • Inactivated Vaccines
        • Subunit Vaccines
        • Toxoid Vaccines
        • DNA Vaccines
        • Recombinant Vaccines
      • By Species
        • Canine
        • Avian
        • Feline
      • By Distribution Channel
        • Veterinary Clinics
        • Veterinary Hospitals
        • Veterinary Research Institutes
        • Retail Pharmacies & Others
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Bayer Healthcare *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Vétoquinol S.A
    • Boehringer Ingelheim
    • Ceva Sante Animal S.A.
    • Eli Lilly and Company (Elcano)
    • Heska Co.
    • Merck Animal Health
    • Merial (Boehringer Ingelheim)
    • Virbac
    • Zoetis

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Species
      • Market Snippet, By Distribution Channel
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Product Launch
    • Regulatory Scenario
  4. Global Companion Animal Vaccines Market, By Product Type, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Attenuated Live Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Conjugate Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Inactivated Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Subunit Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Toxoid Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • DNA Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Recombinant Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
  5. Global Companion Animal Vaccines Market, By Species, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Canine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Avian
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Feline
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
  6. Global Companion Animal Vaccines Market, By Distribution Channel, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Veterinary Clinics
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Veterinary Hospitals
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Veterinary Research Institutes
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Retail Pharmacies & Others
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  7. Global Electronic Medical Records Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Species, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Species, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Species, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Species, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Species, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Species, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Company Profiles
      • Bayer Healthcare
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Vétoquinol S.A
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Boehringer Ingelheim
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Ceva Sante Animal S.A.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Eli Lilly and Company (Elcano)
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Heska Co.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Merck Animal Health
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Merial (Boehringer Ingelheim)
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Virbac
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Zoetis
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 24 market data tables and 20 figures on “Companion Animal Vaccines – Global forecast to 2027.

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner